Juan A. Marchal
Granada, AN 18016, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 224 publications
Immunosuppressive roles of pericytes in cancer disease: insights from a systematic review and meta-analysis.
Journal: Journal of translational medicine
Published: February 20, 2026
Corrigendum to 'Improving tumor treatment: Cell membrane-coated nanoparticles for targeted therapies' [Mater. Today Bio, Volume 32, June 2025, 101716].
Journal: Materials today. Bio
Published: February 02, 2026
Modulation of Human Immune Cells by Propyl-Propane Thiosulfonate (PTSO) Inhibits Colorectal Tumor Progression in a Humanized Mouse Model.
Journal: Nutrients
Published: August 26, 2025
Evaluation of recombinant trypsinogen and chymotrypsinogen production in Komagataella phaffii through co-expression of HAC1 and PDI1.
Journal: Microbial cell factories
Published: July 03, 2025
Langmuir film approach with breast cancer and fibroblast cell membranes to explore their interaction with doxorubicin.
Journal: Journal of colloid and interface science
Published: April 20, 2025
Establishing a Bioink Assessment Protocol: GelMA and Collagen in the Bioprinting of a Potential In Vitro Intestinal Model.
Journal: ACS biomaterials science & engineering
Published: March 25, 2025
Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.
Journal: International journal of biological sciences
Published: February 22, 2025
A Novel Sprayable Fibrinogen/Glycosaminoglycans/Collagen-Based Bioink for Skin Wound Healing Applied by a Handheld Dual-Head Airbrush.
Journal: Advanced healthcare materials
Published: February 07, 2025
Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts.
Journal: Scientific reports
Published: January 30, 2025
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells.
Journal: International journal of molecular sciences
Published: January 25, 2025
Tigecycline suppresses colon cancer stem cells and impairs tumor engraftment by targeting SNAI1-regulated epithelial-mesenchymal transition.
Journal: Acta pharmacologica Sinica
Published: January 17, 2025
Last Updated: 09/26/2026